Gender diversity in biotech
I just ran across this report about gender diversity in biotech boardrooms (spoiler: it’s not great).
An optimistic output of the study is that almost 58% of the studied boards now have women serving on them.
There is nothing optimistic in that statistic - a little less than half of boards have no women at all. Progress won’t be made so long as we keep framing reality in bullshit ways like this.
…diverse boards (having at least one seat held by a woman)…
I’m sorry, what? One (probably white) woman on the board is enough to be considered “diverse”?